Collaborative Arrangement, Rights and Obligations, Development And Regulatory Milestone Payments, Maximum

No definition available.

Name:	cntx_CollaborativeArrangementRightsAndObligationsDevelopmentAndRegulatoryMilestonePaymentsMaximum
Namespace Prefix:	cntx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Collaborative Arrangement, Rights and Obligations, Milestone Payment

+ References

No definition available.

+ Details

Name:	cntx_CollaborativeArrangementRightsAndObligationsMilestonePayment
Namespace Prefix:	cntx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Collaborative Arrangement, Rights and Obligations, Quarterly Sales Payments, Percent

+ References

No definition available.

+ Details

Name:	cntx_CollaborativeArrangementRightsAndObligationsQuarterlySalesPaymentsPercent
Namespace Prefix:	cntx_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Collaborative Arrangement, Rights and Obligations, Sales Milestone Payments, Maximum

+ References

No definition available.

+ Details

Name:	cntx_CollaborativeArrangementRightsAndObligationsSalesMilestonePaymentsMaximum
Namespace Prefix:	cntx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Research And Development Arrangement, Contract To Perform For Others, Upon Completion, Sales Payment Period

+ References

No definition available.

+ Details

Name:	cntx_CollaborativeArrangementRightsAndObligationsSalesPaymentPeriod
Namespace Prefix:	cntx_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Collaborative Arrangement, Rights and Obligations, Tiered Royalty, Percent

+ References

No definition available.

+ Details

Name:	cntx_CollaborativeArrangementRightsAndObligationsTieredRoyaltyPercent
Namespace Prefix:	cntx_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Collaborative Arrangement, Rights and Obligations, Upfront Payment

+ References

No definition available.

+ Details

Name:	cntx_CollaborativeArrangementRightsAndObligationsUpfrontPayment
Namespace Prefix:	cntx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Temporary Equity, Stock Issued During Period, Shares, Issued For Services

+ References

No definition available.

+ Details

Name:	cntx_TemporaryEquityStockIssuedDuringPeriodSharesIssuedForServices
Namespace Prefix:	cntx_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Temporary Equity, Stock Issued During Period, Value, Issued For Services

+ References

No definition available.

+ Details

Name:	cntx_TemporaryEquityStockIssuedDuringPeriodValueIssuedForServices
Namespace Prefix:	cntx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 912
-SubTopic 730
-Section 25
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 985
-SubTopic 20
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 730
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373

+ Details

Name:	us-gaap_ResearchAndDevelopmentExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.

+ References

No definition available.

+ Details

Name:	us-gaap_WarrantsAndRightsOutstanding
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_SeriesAPreferredStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=cntx_TyligandBioscienceShanghaiLimitedMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=cntx_IntegralMolecularIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=cntx_ScaleUp100KilogramsOfGMPGradeCompoundMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=cntx_ScaleUp300KilogramsOfGMPGradeCompoundMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Commitment and Contingencies - 10Q (Details) - USD ($)	1 Months Ended	3 Months Ended	9 Months Ended
Commitment and Contingencies - 10Q (Details) - USD ($)	Mar. 31, 2020	Jun. 30, 2021	Sep. 30, 2021	Aug. 31, 2021	Apr. 30, 2021
Series A Preferred Stock
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Temporary equity, stock issued for services (in shares)		418,559
Temporary equity, stock issued for services		$ 2,837,832
Tyligand \| Collaborative Arrangement, Transaction with Party to Collaborative Arrangement
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Maximum obligation amount	$ 800,000
Quarterly sales payment due upon completion, percentage	1.00%
Quarterly sales payment due upon completion, period of payment	15 years
Number of securities called by warrants (in shares)				111,576
Warrant exercise price (in dollars per share)				$ 7.17
Warrant fair value		$ 400,000		$ 400,000
Research and development			$ 800,000
Integral \| Collaborative Arrangement, Transaction with Party to Collaborative Arrangement
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Maximum obligation amount			$ 300,000
Maximum development and regulatory milestone payments					$ 55,300,000
Maximum sales milestone payments					$ 130,000,000
Tiered royalty payment, percent (up to)					12.00%
Integral \| Series A Preferred Stock \| Collaborative Arrangement, Transaction with Party to Collaborative Arrangement
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Temporary equity, stock issued for services (in shares)			418,559
Temporary equity, stock issued for services			$ 2,800,000
Scale-up, 100 kilograms of GMP-grade compound \| Tyligand \| Collaborative Arrangement, Transaction with Party to Collaborative Arrangement
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Milestone payment	$ 2,000,000
Scale-up, 300 kilograms of GMP-grade compound \| Tyligand \| Collaborative Arrangement, Transaction with Party to Collaborative Arrangement
Research and Development Arrangement, Contract to Perform for Others [Line Items]
Milestone payment	$ 3,000,000